NDRG2 and Thyroid Cancer
Author Information
Author(s): Zhao Huadong, Zhang Jian, Lu Jianguo, He Xianli, Chen Changsheng, Li Xiaojun, Gong Li, Bao Guoqiang, Fu Qiang, Chen Suning, Lin Wei, Shi Hai, Ma Jianjun, Liu Xinping, Ma Qingjiu, Yao Libo
Primary Institution: The Fourth Military Medical University
Hypothesis
Does NDRG2 participate in the carcinogenesis of thyroid cancer?
Conclusion
NDRG2 expression is significantly decreased in thyroid cancers, suggesting its role in thyroid carcinogenesis.
Supporting Evidence
- NDRG2 mRNA was significantly decreased in thyroid carcinoma tissues compared to adjacent normal tissues.
- Immunostaining analysis revealed a decrease of Ndrg2 expression in thyroid carcinomas.
- Positive amplification of c-Myc was detected in thyroid cancers, while little was seen in adenomas.
Takeaway
This study found that a gene called NDRG2 is less active in thyroid cancer compared to normal thyroid tissue, which might help us understand how thyroid cancer develops.
Methodology
The study used immunohistochemistry, quantitative RT-PCR, and western blot methods to analyze NDRG2 expression in thyroid tissues.
Limitations
The study did not find significant correlations of NDRG2 expression with gender, age, different histotypes of thyroid cancers, or distant metastases.
Participant Demographics
The study included 40 individuals with thyroid adenomas and 35 with thyroid carcinomas, with no significant differences in NDRG2 expression based on gender or age.
Statistical Information
P-Value
0.048
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website